What question did this study set out to answer?

This research aims to assess the evidence surrounding neuraminidase inhibitors, particularly oseltamivir, for treating influenza.

December 8, 2009BMJOpen Access

Neuraminidase inhibitors--the story behind the Cochrane review

View Full Paper

Ask AI

Bookmark

This research aims to assess the evidence surrounding neuraminidase inhibitors, particularly oseltamivir, for treating influenza.
Updated the Cochrane review regarding neuraminidase inhibitors in healthy adults.
Analyzed the public evidence base concerning the drug's clinical effectiveness.
The evidence base for oseltamivir was found to be fragmented and inconsistent.
Significant spending on the drug contrasts with the quality of available public evidence.

No takes yet. Share an insight, caveat, or question.

The Cochrane review reveals inconsistent evidence on neuraminidase inhibitors' efficacy in healthy adults, suggesting gaps in public health data.

Peter Doshi (2009) studied this question.

View Full Paper

Ask AI

Bookmark

The Cochrane review reveals inconsistent evidence on neuraminidase inhibitors' efficacy in healthy adults, suggesting gaps in public health data.